Abstract:Non-coding variation in complex human disease has been well established by genome-wide association studies, and is thought to involve regulatory elements, such as enhancers, whose variation affects the expression of the gene responsible for the disease. The regulatory elements often lie far from the gene they regulate, or within introns of genes differing from the regulated gene, making it difficult to identify the gene whose function is affected by a given enhancer variation. Enhancers are connected to their target gene promoters via long-range physical interactions (loops). In our study, we re-mapped, onto the human genome, more than 10,000 enhancers connected to promoters via long-range interactions, that we had previously identified in mouse brain-derived neural stem cells by RNApolII-ChIA-PET analysis, coupled to ChIP-seq mapping of DNA/chromatin regions carrying epigenetic enhancer marks. These interactions are thought to be functionally relevant. We discovered, in the human genome, thousands of DNA regions syntenic with the interacting mouse DNA regions (enhancers and connected promoters). We further annotated these human regions regarding their overlap with sequence variants (single nucleotide polymorphisms, SNPs; copy number variants, CNVs), that were previously associated with neurodevelopmental disease in humans. We document various cases in which the genetic variant, associated in humans to neurodevelopmental disease, affects an enhancer involved in long-range interactions: SNPs, previously identified by genome-wide association studies to be associated with schizophrenia, bipolar disorder, and intelligence, are located within our human syntenic enhancers, and alter transcription factor recognition sites. Similarly, CNVs associated to autism spectrum disease and other neurodevelopmental disorders overlap with our human syntenic enhancers. Some of these enhancers are connected (in mice) to homologs of genes already associated to the human disease, strengthening the hypothesis that the gene is indeed involved in the disease. Other enhancers are connected to genes not previously associated with the disease, pointing to their possible pathogenetic involvement. Our observations provide a resource for further exploration of neural disease, in parallel with the now widespread genome-wide identification of DNA variants in patients with neural disease.

De novo human brain enhancers created by single-nucleotide mutations

Brain Developmental and Cortical Connectivity Changes in Transgenic Monkeys Carrying the Human-Specific Duplicated Gene SRGAP2C.

Long-Range Enhancer Networks Gradually Emerge as Key Regulators During Human Cortical Neurogenesis

MicroRNA-Driven Developmental Remodeling in the Brain Distinguishes Humans from Other Primates

Enhancers Active in Dopamine Neurons Are a Primary Link Between Genetic Variation and Neuropsychiatric Disease.

Massively parallel disruption of enhancers active during human corticogenesis

Origin and evolution of developmental enhancers in the mammalian neocortex

Human-specific genetic hallmarks in neocortical development: focus on neural progenitors

Mutagenesis Sensitivity Mapping of Human Enhancers

Human-unique brain cell clusters are associated with learning disorders and human episodic memory activity

Mutagenesis Sensitivity Mapping of Human Enhancers In Vivo

A Human‐Specific De Novo Gene Promotes Cortical Expansion and Folding

Extension of cortical synaptic development distinguishes humans from chimpanzees and macaques.

A human-specific enhancer fine-tunes radial glia potency and corticogenesis

Hominini-specific regulation of <i>CBLN2</i> increases prefrontal spinogenesis

Comparative Single-Cell Multiome Identifies Evolutionary Changes in Neural Progenitor Cells During Primate Brain Development

Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease

Evolutionary changes in promoter and enhancer activity during human corticogenesis

The human developing cerebral cortex is characterized by an elevated de novo expression of lncRNAs in excitatory neurons

De novo genes with an lncRNA origin encode unique human brain developmental functionality

Neuronal enhancers fine-tune adaptive circuit plasticity